Advertisement
Review Article| Volume 40, ISSUE 4, P685-700, July 2010

Feline Hypertrophic Cardiomyopathy: An Update

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Veterinary Clinics: Small Animal Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Maron B.J.
        • Towbin J.A.
        • Thiene G.
        • et al.
        Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.
        Circulation. 2006; 113: 1807-1816
        • Thiene G.
        • Corrado D.
        • Basso C.
        Cardiomyopathies: is it time for a molecular classification?.
        Eur Heart J. 2004; 25: 1772-1775
        • Meurs K.M.
        • Sanchez X.
        • David R.M.
        • et al.
        A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy.
        Hum Mol Genet. 2005; 14: 3587-3593
        • Meurs K.M.
        • Norgard M.M.
        • Ederer M.M.
        • et al.
        A substitution mutation in the myosin binding protein C gene in ragdoll hypertrophic cardiomyopathy.
        Genomics. 2007; 90: 261-264
        • Richardson P.
        • McKenna W.
        • Bristow M.
        • et al.
        Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.
        Circulation. 1996; 93: 841-842
        • Maron B.J.
        • McKenna W.J.
        • Elliott P.
        • et al.
        Hypertrophic cardiomyopathy.
        JAMA. 1999; 282: 2302-2303
        • Maron B.J.
        • Epstein S.E.
        Hypertrophic cardiomyopathy: a discussion of nomenclature.
        Am J Cardiol. 1979; 43: 1242-1244
        • Maron B.J.
        • McKenna W.J.
        • Danielson G.K.
        • et al.
        ACC/ESC Clinical expert document on hypertrophic cardiomyopathy: a report of American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and European Society of Cardiology Committee for Practice Guidelines.
        J Am Coll Cardiol. 2003; 42: 1687-1713
        • Roberts W.C.
        Fifty years of hypertrophic cardiomyopathy.
        Am J Cardiol. 2009; 103: 431-434
        • Buchanan J.
        • Baker G.
        • Hill J.
        Aortic embolism in cats: prevalence, surgical treatment and electrocardiography.
        Vet Rec. 1966; 79: 496-506
      1. Holzworth J. University of Pennsylvania Veterinary Extension Quarterly. 1958;151:101.

        • Liu S.K.
        Acquired cardiac lesions leading to congestive heart failure in the cat.
        Am J Vet Res. 1970; 31: 2071-2088
      2. Harpster N. Acquired heart disease in the cat. In: 40th Annual Meeting of the American Animal Hospital Association. San Antonio (TX), April 8--13, 1973. Southbend (IN): American Animal Hospital Association. p. 118.

        • Tilley L.
        Feline cardiology.
        Vet Clin North Am. 1976; 6: 415-432
        • Liu S.K.
        • Tilley L.P.
        Animal models of primary myocardial diseases.
        Yale J Biol Med. 1980; 53: 191-211
        • Moise N.S.
        • Dietze A.E.
        • Mezza L.E.
        • et al.
        Echocardiography, electrocardiography, and radiography of cats with dilatation cardiomyopathy, hypertrophic cardiomyopathy, and hyperthyroidism.
        Am J Vet Res. 1986; 47: 1476-1486
        • Maron B.J.
        Hypertrophic cardiomyopathy: a systematic review.
        JAMA. 2002; 287: 1308-1320
        • Jarcho J.A.
        • McKenna W.
        • Pare J.A.
        • et al.
        Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1.
        N Engl J Med. 1989; 321: 1372-1378
        • Geisterfer-Lowrance A.A.T.
        • Kass S.
        • Tanigawa G.
        • et al.
        A molecular basis for familial hypertrophic cardiomyopathy: a [beta] cardiac myosin heavy chain gene missense mutation.
        Cell. 1990; 62: 999-1006
        • Marian A.J.
        Hypertrophic cardiomyopathy: from genetics to treatment.
        Eur J Clin Invest. 2010; 40: 360-369
        • Bos J.M.
        • Ommen S.R.
        • Ackerman M.J.
        Genetics of hypertrophic cardiomyopathy: one, two, or more diseases?.
        Curr Opin Cardiol. 2007; 22: 193-199
        • Kraus M.S.
        • Calvert C.A.
        • Jacobs G.J.
        Hypertrophic cardiomyopathy in a litter of five mixed-breed cats.
        J Am Anim Hosp Assoc. 1999; 35: 293-296
        • Marin L.
        • VandeWoude S.
        • Boon J.
        • et al.
        Left ventricular hypertrophy in a closed colony of Persian cats [abstract].
        J Vet Intern Med. 1994; 8: 143
        • Meurs K.M.
        • Kittleson M.D.
        • Towbin J.
        • et al.
        Familial systolic anterior motion of the mitral valve and/or hypertrophic cardiomyopathy is apparently inherited as an autosomal dominant trait in a family of American shorthair cats.
        J Vet Intern Med. 1997; 11: 138
        • Nicol R.L.
        • Frey N.
        • Olson E.N.
        From the sarcomere to the nucleus: role of genetics and signaling in structural heart disease.
        Annu Rev Genomics Hum Genet. 2000; 1: 179-223
        • Tardiff J.
        Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes.
        Heart Fail Rev. 2005; 10: 237-248
        • Roberts R.
        • Sigwart U.
        Current concepts of the pathogenesis and treatment of hypertrophic cardiomyopathy.
        Circulation. 2005; 112: 293-296
        • Tsybouleva N.
        • Zhang L.
        • Chen S.
        • et al.
        Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy.
        Circulation. 2004; 109: 1284-1291
        • Atkins C.E.
        • Gallo A.M.
        • Kurzman I.D.
        • et al.
        Risk factors, clinical signs, and survival in cats with a clinical diagnosis of idiopathic hypertrophic cardiomyopathy: 74 cases (1985–1989).
        J Am Vet Med Assoc. 1992; 201: 613-618
        • Rush J.E.
        • Freeman L.M.
        • Fenollosa N.K.
        • et al.
        Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990–1999).
        J Am Vet Med Assoc. 2002; 220: 202-207
        • Fox P.R.
        • Liu S.-K.
        • Maron B.J.
        Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy: an animal model of human disease.
        Circulation. 1995; 92: 2645-2651
        • Smith S.A.
        • Tobias A.H.
        • Fine D.M.
        • et al.
        Corticosteroid-associated congestive heart failure in 12 cats.
        Int J Appl Res Vet Med. 2004; 2: 159-170
        • Cote E.
        • Manning A.M.
        • Emerson D.
        • et al.
        Assessment of the prevalence of heart murmurs in overtly healthy cats.
        J Am Vet Med Assoc. 2004; 225: 384-388
        • Gundler S.
        • Tidholm A.
        • Haggstrom J.
        Prevalence of myocardial hypertrophy in a population of asymptomatic Swedish Maine coon cats.
        Acta Vet Scand. 2008; 50: 22
        • Riesen S.C.
        • Kovacevic A.
        • Lombard C.W.
        • et al.
        Echocardiographic screening of purebred cats: an overview from 2002 to 2005.
        Schweiz Arch Tierheilkd. 2007; 149: 73-76
        • Paige C.F.
        • Abbott J.A.
        • Pyle R.L.
        • et al.
        Prevalence of cardiomyopathy in apparently healthy cats.
        J Am Vet Med Assoc. 2009; 234: 1398-1403
        • Wagner T.
        • Luis Fuentes V.
        • McDermott N.
        • et al.
        Association between cardiac murmurs and left ventricular hypertrophy in 199 healthy adult cats.
        J Vet Intern Med. 2009; 23 ([abstract #29]): 1332
        • Maron B.J.
        • Gardin J.M.
        • Flack J.M.
        • et al.
        Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.
        Circulation. 1995; 92: 785-789
        • Goda A.
        • Yamashita T.
        • Suzuki S.
        • et al.
        Prevalence and prognosis of patients with heart failure in Tokyo: a prospective cohort of Shinken Database 2004–5.
        Int Heart J. 2009; 50: 609-625
        • Maron B.J.
        • Peterson E.E.
        • Maron M.S.
        • et al.
        Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study.
        Am J Cardiol. 1994; 73: 577-580
        • Connolly D.J.
        • Soares Magalhaes R.J.
        • Fuentes V.L.
        • et al.
        Assessment of the diagnostic accuracy of circulating natriuretic peptide concentrations to distinguish between cats with cardiac and non-cardiac causes of respiratory distress.
        J Vet Cardiol. 2009; 11: S41-50
        • Fox P.R.
        • Oyama M.A.
        • Reynolds C.
        • et al.
        Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
        J Vet Cardiol. 2009; 11: S51-61
        • Fox P.
        Feline cardiomyopathies.
        in: Fox P.R. Sisson D. Moise N.S. Textbook of canine and feline cardiology: principles and practice. 2nd edition. WB Saunders Co, Philadelphia1999: 621-678
        • Sherrid M.V.
        Pathophysiology and treatment of hypertrophic cardiomyopathy.
        Prog Cardiovasc Dis. 2006; 49: 123-151
        • Sherrid M.V.
        • Gunsburg D.Z.
        • Moldenhauer S.
        • et al.
        Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy.
        J Am Coll Cardiol. 2000; 36: 1344-1354
        • Levine R.A.
        • Vlahakes G.J.
        • Lefebvre X.
        • et al.
        Papillary muscle displacement causes systolic anterior motion of the mitral valve. Experimental validation and insights into the mechanism of subaortic obstruction.
        Circulation. 1995; 91: 1189-1195
        • Paige C.F.
        • Abbott J.A.
        • Pyle R.L.
        Systolic anterior motion of the mitral valve associated with right ventricular systolic hypertension in 9 dogs.
        J Vet Cardiol. 2007; 9: 9-14
        • Maron B.J.
        • Maron M.S.
        • Wigle E.D.
        • et al.
        The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy.
        J Am Coll Cardiol. 2009; 54: 191-200
        • Maron M.S.
        • Olivotto I.
        • Betocchi S.
        • et al.
        Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.
        N Engl J Med. 2003; 348: 295-303
        • Blanksma P.K.
        Is regional wall stress a stimulus for myocardial hypertrophy in hypertrophic cardiomyopathy?.
        Z Kardiol. 1987; 76: 57-60
        • Deb S.J.
        • Schaff H.V.
        • Dearani J.A.
        • et al.
        Septal myectomy results in regression of left ventricular hypertrophy in patients with hypertrophic obstructive cardiomyopathy.
        Ann Thorac Surg. 2004; 78: 2118-2122
        • Knaapen P.
        • Germans T.
        • Camici P.G.
        • et al.
        Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy.
        Am J Physiol Heart Circ Physiol. 2008; 294: H986-993
        • Celik S.
        • Dagdeviren B.
        • Yildirim A.
        • et al.
        Comparison of coronary flow velocities between patients with obstructive and nonobstructive type hypertrophic cardiomyopathy: noninvasive assessment by Transthoracic Doppler Echocardiography.
        Echocardiography. 2005; 22: 1-7
        • Maron M.S.
        • Olivotto I.
        • Maron B.J.
        • et al.
        The case for myocardial ischemia in hypertrophic cardiomyopathy.
        J Am Coll Cardiol. 2009; 54: 866-875
        • Liu S.K.
        • Roberts W.C.
        • Maron B.J.
        Comparison of morphologic findings in spontaneously occurring hypertrophic cardiomyopathy in humans, cats and dogs.
        Am J Cardiol. 1993; 72: 944-951
        • Efthimiadis G.K.
        • Parcharidou D.G.
        • Giannakoulas G.
        • et al.
        Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy.
        Am J Cardiol. 2009; 104: 695-699
        • Kizilbash A.M.
        • Heinle S.K.
        • Grayburn P.A.
        Spontaneous variability of left ventricular outflow tract gradient in hypertrophic obstructive cardiomyopathy.
        Circulation. 1998; 97: 461-466
        • Geske J.B.
        • Sorajja P.
        • Ommen S.R.
        • et al.
        Left ventricular outflow tract gradient variability in hypertrophic cardiomyopathy.
        Clin Cardiol. 2009; 32: 397-402
        • Maron M.S.
        • Olivotto I.
        • Zenovich A.G.
        • et al.
        Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.
        Circulation. 2006; 114: 2232-2239
        • Rishniw M.
        • Thomas W.P.
        Dynamic right ventricular outflow obstruction: a new cause of systolic murmurs in cats.
        J Vet Intern Med. 2002; 16: 547-552
        • Kittleson M.D.
        • Meurs K.M.
        • Munro M.J.
        • et al.
        Familial hypertrophic cardiomyopathy in Maine coon cats: an animal model of human disease.
        Circulation. 1999; 99: 3172-3180
        • Abbott J.A.
        • MacLean H.N.
        Two-dimensional echocardiographic assessment of the feline left atrium.
        J Vet Intern Med. 2006; 20: 111-119
        • Nistri S.
        • Olivotto I.
        • Betocchi S.
        • et al.
        Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian registry for hypertrophic cardiomyopathy).
        Am J Cardiol. 2006; 98: 960-965
        • Fox P.R.
        Hypertrophic cardiomyopathy. Clinical and pathologic correlates.
        J Vet Cardiol. 2003; 5: 39-45
        • Kubo T.
        • Gimeno J.R.
        • Bahl A.
        • et al.
        Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
        J Am Coll Cardiol. 2007; 49: 2419-2426
        • Nishimura R.A.
        • Ommen S.R.
        Hypertrophic cardiomyopathy: the search for obstruction.
        Circulation. 2006; 114: 2200-2202
        • Shah J.S.
        • Esteban M.T.
        • Thaman R.
        • et al.
        Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy.
        Heart. 2008; 94: 1288-1294
        • Liu S.-K.
        • Maron B.J.
        • Tilley L.P.
        Feline hypertrophic cardiomyopathy: gross anatomic and quantitative histologic features.
        Am J Pathol. 1981; 102: 388-395
        • Sisson D.D.
        • Knight D.H.
        • Helinski C.
        • et al.
        Plasma taurine concentrations and M-mode echocardiographic measures in healthy cats and in cats with dilated cardiomyopathy.
        J Vet Intern Med. 1991; 5: 232-238
        • Drourr L.
        • Lefbom B.K.
        • Rosenthal S.L.
        • et al.
        Measurement of M-mode echocardiographic parameters in healthy adult Maine Coon cats.
        J Am Vet Med Assoc. 2005; 226: 734-737
        • Connolly D.J.
        • Soares Magalhaes R.J.
        • Syme H.M.
        • et al.
        Circulating natriuretic peptides in cats with heart disease.
        J Vet Intern Med. 2008; 22: 96-105
        • Wess G.
        • Daisenberger P.
        • Hirschberger J.
        • et al.
        The utility of NT-proBNP to detect early stages of hypertrophic cardiomyopathy in cats and to differentiate disease stages.
        J Vet Intern Med. 2009; 23 ([abstract 9]): 687
        • Fox P.R.
        • Oyama M.A.
        • MacDonald K.A.
        • et al.
        Assessment of NT proBNP concentration in asymptomatic cats with cardiomyopathy.
        J Vet Intern Med. 2008; 22 ([abstract 191]): 759
        • Hsu A.
        • Kittleson M.D.
        • Paling A.
        Investigation into the use of plasma NT-proBNP concentration to screen for feline hypertrophic cardiomyopathy.
        J Vet Cardiol. 2009; 11: S63-70
        • Baty C.J.
        • Malarkey D.E.
        • Atkins C.E.
        • et al.
        Natural history of hypertrophic cardiomyopathy and aortic thromboembolism in a family of domestic shorthair cats.
        J Vet Intern Med. 2001; 15: 595-599
        • Fox P.R.
        Prospective, double-blinded, multicenter evaluation of chronic therapies for feline diastolic heart failure: interim analysis [abstract].
        J Vet Intern Med. 2003; 17: 398
        • MacDonald K.A.
        • Kittleson M.D.
        • Larson R.F.
        • et al.
        The effect of ramipril on left ventricular mass, myocardial fibrosis, diastolic function, and plasma neurohormones in Maine Coon cats with familial hypertrophic cardiomyopathy without heart failure.
        J Vet Intern Med. 2006; 20: 1093-1105
        • Amberger C.N.
        • Glardon O.
        • Glaus T.
        • et al.
        Effects of benazepril in the treatment of feline hypertrophic cardiomyopathy: results of a prospective, open-label, multicenter clinical trial.
        J Vet Cardiol. 1999; 1: 19-26
        • MacDonald K.A.
        • Kittleson M.D.
        • Kass P.H.
        Effect of spironolactone on diastolic function and left ventricular mass in Maine Coon cats with familial hypertrophic cardiomyopathy.
        J Vet Intern Med. 2008; 22: 335-341
        • Johnson LM
        • Atkins CE
        • Keene BW
        • et al.
        Pharmacokinetic and pharmacodynamic properties of conventional and CD-formulated diltiazem in cats.
        J Vet Intern Med. 1996; 10: 316-320
        • Bright J.M.
        • Golden A.L.
        • Gompf R.E.
        • et al.
        Evaluation of the calcium channel-blocking agents diltiazem and verapamil for treatment of feline hypertrophic cardiomyopathy.
        J Vet Intern Med. 1991; 5: 272-282
        • Rush JE
        • Freeman LM
        • Brown DJ
        • et al.
        The use of enalapril in the treatment of feline hypertrophic cardiomyopathy.
        J Am Anim Hosp Assoc. 1998; 34: 38-41
      3. Fox PR. Newest developments: feline heart disease and management. In: Proceedings of the North American Veterinary Conference. Orlando (FL), January 17–21, 2004. Gainesville (FL): Eastern States Veterinary Association. p. 133–5.